Current Advances in Relapsed/Refractory MCL: Expert Guidance for Community Hematology Care Teams

Learn more about the current and emerging role of BTK inhibitors in the optimal care of patients with relapsed/refractory MCL, and gain expert insight on personalized approaches to prevent, mitigate and manage the adverse events associated with BTK inhibitors, featuring an on-demand webcast and downloadable slideset from a live workshop series.

Share

Program Content

No activities added yet

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by educational grants from Beigene, Ltd. and Lilly.

BeiGene, Ltd.

Lilly